BVF PARTNERS L P/IL
Transaction: 01/28/2026
SELL
Change
-548,938
Price
$2.20
Filing
01/30/2026
Type
SELL
Repare Therapeutics Inc.
RPTX • Biotechnology
$2.65
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2025
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$114.09M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 330.9%Manageable debt level · 0.01Healthy liquidity · 6.77Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 14, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.65
Change0.00%
Shares Out43.05M
Market Cap$114.09M
Enterprise Value$1.48M
52W Range0.89 - 2.66
Beta0.96
P/E-1.58
P/S9.61
P/B0.99
P/FCF-1.63
EV/Sales0.12
Price$2.65
Change0.00%
Shares Out43.05M
Market Cap$114.09M
Enterprise Value$1.48M
52W Range0.89 - 2.66
Beta0.96
P/E-1.58
P/S9.61
P/B0.99
P/FCF-1.63
EV/Sales0.12
EV/EBITDA-0.02
EV/FCF-0.02
Earnings Yield-63.28%
FCF Yield-61.49%
Dividend Yield0.00%
Gross Margin74.98%
Oper. Margin-174.88%
Profit Margin-158.37%
Debt/Eq0.01
Current Ratio6.77
Quick Ratio6.77
Target$16.00
Target Upside503.77%
Target Median$15.00
Target Range3.00 - 30.00
Volume1.17M
Avg Volume1.18M
EPS Surprise-0.38
Investment DNA
How strong this company looks for long-term investors
57
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Positive revenue growth · 330.9%Manageable debt level · 0.01Healthy liquidity · 6.77Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
89/100
Bullish
Bullish
7
Hold
2
Bearish
0
Price Target
2026-06-06
Low
$3.00
Mean
$16.00
Median
$15.00
High
$30.00
Insider Transactions
Recent executive and insider activity
⚠ 2 high-volume insider sells detected
Alves Sandra Isabelle Barros
Transaction: 01/28/2026
SELL
Change
-31,622
Price
$2.20
Filing
01/28/2026
Type
SELL
Alves Sandra Isabelle Barros
Transaction: 01/28/2026
SELL
Change
-24,500
Price
$1.07
Filing
01/28/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | SELL | -548,938 | $2.20 | 01/28/2026 | 01/30/2026 |
| Alves Sandra Isabelle Barros | SELL | -31,622 | $2.20 | 01/28/2026 | 01/28/2026 |
| Alves Sandra Isabelle Barros | SELL | -24,500 | $1.07 | 01/28/2026 | 01/28/2026 |
| Forte Steve | SELL | -56,786 | $2.20 | 01/28/2026 | 01/28/2026 |
| Forte Steve | SELL | -500,000 | $1.07 | 01/28/2026 | 01/28/2026 |
| Civik Thomas | SELL | -7,500 | $2.20 | 01/28/2026 | 01/28/2026 |
| RHOADS ANN D | SELL | -4,000 | $2.20 | 01/28/2026 | 01/28/2026 |
| SCHAFER CAROL | SELL | -8,000 | $2.20 | 01/28/2026 | 01/28/2026 |
| SCHAFER CAROL | SELL | -37,941 | $2.06 | 01/28/2026 | 01/28/2026 |
| Alves Sandra Isabelle Barros | BUY | +24,500 | $1.07 | 04/02/2025 | 04/29/2025 |
| Alves Sandra Isabelle Barros | BUY | +4,100 | Not reported | 04/02/2025 | 04/29/2025 |
| Alves Sandra Isabelle Barros | OTHER | +21,565 | $36.91 | 03/31/2025 | 04/29/2025 |
| Alves Sandra Isabelle Barros | OTHER | 0 | Not reported | 03/31/2025 | 04/29/2025 |
| Forte Steve | BUY | +500,000 | $1.07 | 04/02/2025 | 04/04/2025 |
| Segal Lloyd Mitchell | SELL | -21,179 | $1.14 | 03/12/2025 | 03/14/2025 |
| Forte Steve | SELL | -6,884 | $1.14 | 03/12/2025 | 03/14/2025 |
| Zinda Michael | SELL | -5,611 | $1.14 | 03/12/2025 | 03/14/2025 |
| Koehler Maria | SELL | -3,596 | $1.14 | 03/12/2025 | 03/14/2025 |
| Forte Steve | BUY | +14,000 | Not reported | 03/04/2025 | 03/06/2025 |
| Forte Steve | BUY | +85,000 | $1.17 | 03/04/2025 | 03/06/2025 |